RecruitingNCT03333200
Longitudinal Study of Neurodegenerative Disorders
Sponsor
University of Pittsburgh
Enrollment
1,500 participants
Start Date
Jan 11, 2012
Study Type
OBSERVATIONAL
Conditions
Gaucher DiseaseBatten DiseaseLeukodystrophyALDKrabbe DiseaseMLDPelizaeus-Merzbacher DiseaseVanishing White Matter DiseaseMultiple Sulfatase Deficiency DiseaseNiemann-Pick DiseasesSandhoff DiseaseTay-Sachs DiseaseAlpha-MannosidosisMPS ILysosomal Storage DiseasesMPS IIMPS IIIGM3 GangliosidosisPKANNP DeficiencyOsteopetrosisMPS IVGANGM1 GangliosidosesMorquio DiseaseS-Adenosylhomocysteine Hydrolase DeficiencyPurine Nucleoside Phosphorylase Deficiency
Summary
The purpose of this study is to understand the course of rare genetic disorders that affect the brain. This data is being analyzed to gain a better understanding of the progression of the rare neurodegenerative disorders and the effects of interventions.
Eligibility
Inclusion Criteria1
- Any patient with a genetic neurodegenerative disorder
Exclusion Criteria1
- none
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERPalliative Care
Collecting information about the natural progression of these diseases
BIOLOGICALHematopoetic Stem Cell Transplantation
Following patients who have received HSCT as part of their clinical care.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03333200
Related Trials
Krabbe Disease Global Patient Registry
NCT029937961 location
A Clinical Trial of PR001 (LY3884961) in Patients With Peripheral Manifestations of Gaucher Disease (PROCEED)
NCT054875999 locations
An Open-Label Exploratory Study of Fosigotifator in Participants With Vanishing White Matter Disease
NCT057571415 locations
Gene-Modified Stem Cell Therapy for Children With Autosomal Recessive Osteopetrosis (ARO)
NCT076650211 location
A Pilot Study for Systematic Neonatal Screening for Lysosomal Storage Diseases Using Tandem Mass Spectrometry
NCT043937012 locations